EA201991265A1 - Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат - Google Patents
Лекарственные формы с отсроченным высвобождением, содержащие диметилфумаратInfo
- Publication number
- EA201991265A1 EA201991265A1 EA201991265A EA201991265A EA201991265A1 EA 201991265 A1 EA201991265 A1 EA 201991265A1 EA 201991265 A EA201991265 A EA 201991265A EA 201991265 A EA201991265 A EA 201991265A EA 201991265 A1 EA201991265 A1 EA 201991265A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- delayed delivery
- medicinal forms
- delivery containing
- containing dimethylfumarate
- dimethylfumarate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к фармацевтической композиции с отсроченным высвобождением, содержащей диметилфумарат и по меньшей мере одно фармацевтически приемлемое вспомогательное вещество.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2016/16998A TR201616998A1 (en) | 2016-11-23 | 2016-11-23 | DELAYED RELEASE DOSING FORMS WITH DIMETHYL FUMARATE |
PCT/EP2017/080120 WO2018095996A1 (en) | 2016-11-23 | 2017-11-22 | Delayed release dosage forms comprising dimethyl fumarate |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201991265A1 true EA201991265A1 (ru) | 2019-10-31 |
Family
ID=60450512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991265A EA201991265A1 (ru) | 2016-11-23 | 2017-11-22 | Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP3326653A1 (ru) |
EA (1) | EA201991265A1 (ru) |
TR (1) | TR201616998A1 (ru) |
WO (1) | WO2018095996A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201818293A2 (tr) * | 2018-11-30 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Di̇meti̇l fumarat i̇çeren geci̇kmeli̇ salim sağlayan kapsül |
CN113004699B (zh) * | 2019-12-20 | 2022-11-29 | 洛阳尖端技术研究院 | 一种硅橡胶及其制品 |
WO2022254356A1 (en) * | 2021-06-04 | 2022-12-08 | Zim Laboratories Limited | Delayed release compositions of dimethyl fumarate |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19853487A1 (de) * | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
WO2013076216A1 (en) * | 2011-11-24 | 2013-05-30 | Synthon Bv | Controlled release particles comprising dimethyl fumarate |
NZ627980A (en) | 2012-02-07 | 2016-12-23 | Biogen Ma Inc | Pharmaceutical compositions containing dimethyl fumarate |
US9410659B2 (en) * | 2014-02-10 | 2016-08-09 | The Boeing Company | Automated mobile boom system for crawling robots |
AU2015222880B2 (en) * | 2014-02-28 | 2016-11-24 | Banner Life Sciences Llc | Controlled release enteric soft capsules of fumarate esters |
WO2016113754A2 (en) * | 2015-01-14 | 2016-07-21 | Leiutis Pharmaceuticals Pvt, Ltd. | Novel oral dosage forms of dimethyl fumarate |
WO2016147108A1 (en) * | 2015-03-17 | 2016-09-22 | Hetero Research Foundation | Pharmaceutical compositions of dimethyl fumarate |
WO2017145036A1 (en) * | 2016-02-25 | 2017-08-31 | Aurobindo Pharma Ltd | Pharmaceutical compositions comprising dimethyl fumarate |
-
2016
- 2016-11-23 TR TR2016/16998A patent/TR201616998A1/en unknown
-
2017
- 2017-11-22 EP EP17203118.9A patent/EP3326653A1/en not_active Withdrawn
- 2017-11-22 EA EA201991265A patent/EA201991265A1/ru unknown
- 2017-11-22 WO PCT/EP2017/080120 patent/WO2018095996A1/en active Application Filing
- 2017-11-22 EP EP19152301.8A patent/EP3513811A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2018095996A1 (en) | 2018-05-31 |
EP3513811A1 (en) | 2019-07-24 |
EP3326653A1 (en) | 2018-05-30 |
TR201616998A1 (en) | 2018-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502742A1 (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
MX2018007704A (es) | Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante. | |
MY191574A (en) | Pharmaceutical compositions comprising meloxicam | |
CO2017013293A2 (es) | Formulaciones farmacéuticas que comprenden tenofovir y emtricitabina | |
EA201792591A1 (ru) | Фармацевтические препараты | |
IL281177A (en) | Dengue fever vaccine unit dose and its administration | |
ECSP17044282A (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
PH12016501841A1 (en) | Immunosuppressant formulation | |
EA201991265A1 (ru) | Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат | |
MX2018005358A (es) | Comprimido de dosis alta que contiene mesalazina optimizado. | |
EA202090542A1 (ru) | Высококонцентрированные лекарственные формы придопидина | |
IN2013MU01985A (ru) | ||
EA201991287A1 (ru) | Твердые фармацевтические композиции на основе тикагрелора для перорального применения | |
EP3826627C0 (de) | Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung | |
MX2021003230A (es) | Composiciones farmaceuticas que comprenden meloxicam. | |
MD20180049A2 (ru) | Фармацевтическая композиция | |
CL2018003338A1 (es) | Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant. | |
EA201691422A1 (ru) | Перорально распадающиеся таблетированные составы мемантина | |
EA201991007A1 (ru) | Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения | |
IN2013MU02015A (ru) | ||
IN2013MU03370A (ru) | ||
BR112018006206A2 (pt) | composição, uso de uma combinação, forma de dosagem fixa farmacêutica, combinação de dosagem fixa, embalagem, e, uso de uma combinação de dose fixa | |
IN2014MU00781A (ru) | ||
TR201721065A2 (tr) | Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar | |
CR20190161A (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terpéutico del mismo |